Bifalgorithm post · Canada has the strengths to lead in life sciences · Strength meets a structural gap

Policy Priorities

Policy Priorities (Canada has the strengths to lead in life sciences · Strength meets a structural gap) — "Mr. Magnelli sees a rare opportunity in this moment.…

Ideas in this flowchart

  • A rare opportunity exists to advance pharmaceutical policy in Canada.
  • In July, the federal Pharmaceutical and Life Sciences Sector Task Force produced recommendations.
  • Government, industry, and patient groups broadly agree on the recommendations.
  • The priority is to move from recommendations to implementation.
  • Implementation priorities
  • Modernize health technology assessment and pan-Canadian Pharmaceutical Alliance approaches to reflect the full clinical, patient, and societal value of a treatment.
  • Improve time to patient access.
  • Reform Canada’s Drug Agency (CDA-AMC).
  • Enhance federal investment for innovative medicines.
Bifalgorithm
Sign up
Feed/

Policy Priorities

No cover

Channel

Canada has the strengths to lead in life sciences

1 page

U
USR292600b83e2a
Ebook2w

"Mr. Magnelli sees a rare opportunity in this moment. In July, the federal government’s Pharmaceutical and Life Sciences Sector Task Force has produced recommendations that government, industry and patient groups broadly agree on, he says, and now is the time to move from recommendations to implementation. Priorities include: modernizing health technology assessment and pan-Canadian Pharmaceutical Alliance (pCPA) approaches to reflect the full clinical, patient and societal value of a treatment; improving time to patient access; reforming Canada’s Drug Agency (CDA-AMC); and enhancing federal investment for innovative medicines."

Flowchart preview
👍
0
0 comments0 shares

Sign in to view and post comments.